Perrine Roux

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study

Perrine Roux, Patrizia Carrieri, Virgine Villes et al. · Addiction · 2008 · 126 citations

Public Health, Pharmacotherapy, Hiv Control +16

Retention in Opioid Substitution Treatment: A Major Predictor of Long‐Term Virological Success for HIV‐Infected Injection Drug Users Receiving Antiretroviral Treatment

Perrine Roux, Patrizia Carrieri, Julien Cohen et al. · Clinical Infectious Diseases · 2009 · 115 citations

Public Health, Pharmacotherapy, Hiv Control +15

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data

Camélia Protopopescu, F. Raffi, Perrine Roux et al. · Journal of Antimicrobial Chemotherapy · 2009 · 107 citations · Full text

Public Health, Pharmacotherapy, Clinical Epidemiology +16

Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations

Sharon Stancliff, Herman Joseph, Chunki Fong et al. · Journal of Addictive Diseases · 2012 · 90 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17

Innovative community‐based educational face‐to‐face intervention to reduce HIV, hepatitis C virus and other blood‐borne infectious risks in difficult‐to‐reach people who inject drugs: results from the ANRS–AERLI intervention study

Perrine Roux, Jean‐Marie Le Gall, Marie Debrus et al. · Addiction · 2015 · 63 citations

Public Health, Community Health, Health Education +17